Agilent Technologies Inc (A) Holdings Lifted by State of Alaska Department of Revenue

State of Alaska Department of Revenue grew its position in Agilent Technologies Inc (NYSE:A) by 190.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 57,154 shares of the medical research company’s stock after buying an additional 37,460 shares during the quarter. State of Alaska Department of Revenue’s holdings in Agilent Technologies were worth $3,826,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in the business. Advisor Group Inc. lifted its position in shares of Agilent Technologies by 0.3% in the second quarter. Advisor Group Inc. now owns 3,959 shares of the medical research company’s stock worth $235,000 after purchasing an additional 10 shares in the last quarter. Veritable L.P. lifted its position in shares of Agilent Technologies by 0.4% in the second quarter. Veritable L.P. now owns 10,896 shares of the medical research company’s stock worth $646,000 after purchasing an additional 40 shares in the last quarter. Balentine LLC lifted its position in shares of Agilent Technologies by 2.9% in the second quarter. Balentine LLC now owns 1,794 shares of the medical research company’s stock worth $106,000 after purchasing an additional 50 shares in the last quarter. Kingfisher Capital LLC lifted its position in shares of Agilent Technologies by 0.3% in the second quarter. Kingfisher Capital LLC now owns 22,643 shares of the medical research company’s stock worth $1,343,000 after purchasing an additional 58 shares in the last quarter. Finally, Quadrant Capital Group LLC lifted its position in shares of Agilent Technologies by 2.4% in the second quarter. Quadrant Capital Group LLC now owns 5,604 shares of the medical research company’s stock worth $317,000 after purchasing an additional 134 shares in the last quarter.

A has been the topic of several recent research reports. Zacks Investment Research raised shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $76.00 price objective on the stock in a research report on Tuesday, October 31st. Barclays reaffirmed a “buy” rating and set a $74.00 price objective on shares of Agilent Technologies in a research report on Monday, January 8th. Robert W. Baird reaffirmed a “buy” rating and set a $70.00 price objective on shares of Agilent Technologies in a research report on Friday, October 20th. Evercore ISI initiated coverage on shares of Agilent Technologies in a research report on Wednesday, January 3rd. They set an “outperform” rating and a $75.00 price objective on the stock. Finally, Cowen reaffirmed a “hold” rating and set a $65.00 price objective on shares of Agilent Technologies in a research report on Thursday, September 28th. Six equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $69.25.

Agilent Technologies Inc (A) opened at $73.48 on Tuesday. Agilent Technologies Inc has a 52-week low of $47.05 and a 52-week high of $73.55. The company has a market cap of $23,650.00, a P/E ratio of 35.16, a PEG ratio of 2.21 and a beta of 1.28. The company has a debt-to-equity ratio of 0.37, a current ratio of 3.30 and a quick ratio of 2.85.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Monday, November 20th. The medical research company reported $0.67 EPS for the quarter, beating the Zacks’ consensus estimate of $0.62 by $0.05. Agilent Technologies had a net margin of 15.30% and a return on equity of 16.95%. The company had revenue of $1.19 billion for the quarter, compared to analyst estimates of $1.17 billion. During the same quarter last year, the firm posted $0.59 earnings per share. The company’s quarterly revenue was up 7.0% compared to the same quarter last year. sell-side analysts forecast that Agilent Technologies Inc will post 2.58 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 24th. Stockholders of record on Tuesday, January 2nd will be given a $0.149 dividend. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.13. The ex-dividend date of this dividend is Friday, December 29th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.81%. Agilent Technologies’s dividend payout ratio (DPR) is currently 28.71%.

In other news, CEO Michael R. Mcmullen sold 21,850 shares of the firm’s stock in a transaction on Thursday, January 18th. The shares were sold at an average price of $72.50, for a total value of $1,584,125.00. Following the sale, the chief executive officer now owns 324,687 shares in the company, valued at $23,539,807.50. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Michael R. Mcmullen sold 43,703 shares of the firm’s stock in a transaction on Friday, January 5th. The stock was sold at an average price of $70.00, for a total transaction of $3,059,210.00. Following the completion of the sale, the chief executive officer now owns 302,837 shares in the company, valued at approximately $21,198,590. The disclosure for this sale can be found here. In the last three months, insiders sold 198,141 shares of company stock worth $13,830,045.

ILLEGAL ACTIVITY WARNING: “Agilent Technologies Inc (A) Holdings Lifted by State of Alaska Department of Revenue” was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The original version of this story can be read at https://www.dispatchtribunal.com/2018/01/23/agilent-technologies-inc-a-holdings-lifted-by-state-of-alaska-department-of-revenue.html.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply